Abstract
In 2006, the human papillomavirus (HPV) vaccine received FDA approval for prevention of HPV-related cancers in women, and routine vaccination of all U.S. girls aged 11 to 12 years was recommended by the Advisory Committee on Immunization Practices. The vaccine is most effective if given before the onset of sexual activity. Uptake of the …
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
